14/10/2005
Minister opens Recordati Ringaskiddy plant
Minister for Enterprise, Trade and Employment Micheál Martin recently opened the new Active Pharmaceutical Ingredients Plant in Ringaskiddy, Co. Cork, for Recordati S.p.A., a European pharmaceutical group based in Milan, Italy.
The €28 million investment, which was announced in January 2003 and is supported by IDA Ireland, is part of Recordati’s strategy to grow internationally. It will involve manufacturing, an international marketing operation, customer support group and an R&D Centre. With 25 people already recruited, it is expected to employ over 60 people at full production.
Minister Martin said “This is an excellent example of the type of investment IDA Ireland is seeking to attract to Ireland as it combines R&D, manufacturing and support functions in a quality, high value operation. This investment continues Ireland’s success in attracting pharmaceutical companies that operate at the leading-edge of their business, both in terms of products and future developments. I congratulate Recordati for the speed with which they have made this investment a reality and I wish them well for a rapid build up and the success of this plant into the future.”
Recordati is dedicated to the research, development, manufacturing and marketing of pharmaceuticals and pharmaceutical chemicals.
The firm's products are used in several therapeutic areas which include cardiovascular, central nervous systems, anti-infective, respiratory, analgesia, gastrointestinal and gyne/urology.
(SP)
The €28 million investment, which was announced in January 2003 and is supported by IDA Ireland, is part of Recordati’s strategy to grow internationally. It will involve manufacturing, an international marketing operation, customer support group and an R&D Centre. With 25 people already recruited, it is expected to employ over 60 people at full production.
Minister Martin said “This is an excellent example of the type of investment IDA Ireland is seeking to attract to Ireland as it combines R&D, manufacturing and support functions in a quality, high value operation. This investment continues Ireland’s success in attracting pharmaceutical companies that operate at the leading-edge of their business, both in terms of products and future developments. I congratulate Recordati for the speed with which they have made this investment a reality and I wish them well for a rapid build up and the success of this plant into the future.”
Recordati is dedicated to the research, development, manufacturing and marketing of pharmaceuticals and pharmaceutical chemicals.
The firm's products are used in several therapeutic areas which include cardiovascular, central nervous systems, anti-infective, respiratory, analgesia, gastrointestinal and gyne/urology.
(SP)
Related Northern Ireland Recruitment News Stories
Click here for the latest headlines.
13 February 2012
Abbott To Invest €85m In Pharmaceutical Expansion
Abbott plans to invest €85 million at its pharmaceutical manufacturing operation in Sligo. The investment will result in the creation of up to approximately 175 highly skilled jobs. The expansion of the facility will be completed in 2014. The investment is supported by the Irish Government through IDA Ireland.
Abbott To Invest €85m In Pharmaceutical Expansion
Abbott plans to invest €85 million at its pharmaceutical manufacturing operation in Sligo. The investment will result in the creation of up to approximately 175 highly skilled jobs. The expansion of the facility will be completed in 2014. The investment is supported by the Irish Government through IDA Ireland.
11 July 2013
140 Construction Jobs To Be Created In Pfizer Expansion
Labour Deputy Robert Dowds, has welcomed the €130 million investment announced by Pfizer today, in two of its sites in Grange Castle, Dublin and Ringaskiddly in Co. Cork. He said: "This news is a strong indication of confidence in the Irish economy by a prominent multinational and major employer.
140 Construction Jobs To Be Created In Pfizer Expansion
Labour Deputy Robert Dowds, has welcomed the €130 million investment announced by Pfizer today, in two of its sites in Grange Castle, Dublin and Ringaskiddly in Co. Cork. He said: "This news is a strong indication of confidence in the Irish economy by a prominent multinational and major employer.
07 July 2009
€11M Investment At Cork Plant Announced
The Tánaiste has announced pharmaceutical company Pfizer is to invest over €11 million in the establishment of an R&D facility in Cork. Pfizer, one of the world’s largest research-based biomedical and pharmaceutical companies will establish an R&D Kilo Technology Laboratory at its Ringaskiddy site in Cork.
€11M Investment At Cork Plant Announced
The Tánaiste has announced pharmaceutical company Pfizer is to invest over €11 million in the establishment of an R&D facility in Cork. Pfizer, one of the world’s largest research-based biomedical and pharmaceutical companies will establish an R&D Kilo Technology Laboratory at its Ringaskiddy site in Cork.
20 July 2009
Harney Opens Dublin Factory
A new state-of-the-art manufacturing plant in Dublin has been officially opened by the Health Minister Mary Harney . It which will house one of Japan's largest pharmaceutical firms and give a boost to employment opportunities.
Harney Opens Dublin Factory
A new state-of-the-art manufacturing plant in Dublin has been officially opened by the Health Minister Mary Harney . It which will house one of Japan's largest pharmaceutical firms and give a boost to employment opportunities.
11 February 2015
Tralee To Benefit From Capital Investment Programme
Labour party TD Arthur J Spring has welcomed the Government's announcement of its five-year Action Plan for Jobs regional strategy, which will accelerate the jobs recovery in all parts of the country.
Tralee To Benefit From Capital Investment Programme
Labour party TD Arthur J Spring has welcomed the Government's announcement of its five-year Action Plan for Jobs regional strategy, which will accelerate the jobs recovery in all parts of the country.